I admit it -- I thought the PC market was about done growing by double digits. Shows you how much I know.
Yesterday, researchers IDC and Gartner
Both firms attributed the growth to consumer interest in notebook computers and very low-cost PCs. They also said businesses continued upgrading older systems. International expansion, too, was a major factor in the results. Indeed, IDC said Europe, the Middle East, and Africa saw a 20% uptick and that demand in the Asia-Pacific region improved. Growth in the U.S. picked up, as well.
Not surprisingly, the big winners were Apple
But can the expansion continue? At the moment, it certainly seems so. With 6.5 billion people on this little planet of ours (give or take a few million), the majority of whom reside in developing parts of the world, there's a good chance many of them don't yet have personal computers. And those who do are going mobile, or perhaps treating their existing machines as consumables to be replaced as often as (or even more often than) a vehicle. Which of course means there could be plenty of headroom left in the global market, which would in turn power big gains for at least one of the stocks in this sector.
Wall Street's so-called experts would probably say Apple or Dell will get the lion's share, and this is one time I'd tend to agree with them.
Your upgrade in techie Foolishness is just a click away:
- Computer distributor CDW is all about the cash.
- HP breaks up with its PC division. The marriage didn't even last six months.
- Dell wants to be Apple.
Fool contributor Tim Beyers will stick with his Mac PowerBook, thank you very much. Tim didn't own shares in any of the companies mentioned in this story at the time of publication. You can find out exactly what's in his portfolio by checking his Fool profile here. The Motley Fool has an ironclad disclosure policy.
More from The Motley Fool
Facebook Officially Launches WhatsApp Business
Monetization is on the horizon.
What Happened in the Stock Market Today
On a record day for the market, Halliburton reported a strong quarter and Sanofi is buying Bioverativ in a big biotech deal.
Why II-VI, Sanmina, and Idera Pharmaceuticals Slumped Today
Find out which company announced a merger.